FTC Illumina Parries FTC Challenge to Grail Acquisition With Deals for Competing Customers Premium The US Federal Trade Commission's recent challenge raises the question who Illumina can acquire while remaining a quasi-monopolist for sequencing equipment. FTC Moves to Block Illumina's $8B Grail Acquisition Illumina said it plans to "vigorously defend" the deal and oppose the FTC, which previously helped scuttle Illumina's proposed acquisition of Pacific Biosciences. FDA Warns Consumers About Fraudulent At-Home COVID-19 Test Kits The US Food and Drug Administration said it plans to aggressively pursue companies selling unproven products for diagnosing, preventing, or treating COVID-19. Illumina, Pacific Biosciences Abandon $1.2B Acquisition Deal Illumina will pay Pacific Biosciences a termination fee of $98 million, in accordance with the merger agreement, originally announced in November 2018. National Council on Disability Recommends More Regulation of NIPT The nonpartisan federal agency's report suggests ways for Congress, the FDA, FTC, and CMS to expand oversight of the genetic testing market. Jan 31, 2014 FTC Says Sale of Certain Thermo Fisher Assets to GE Healthcare is Required for Life Tech Deal OK Jan 8, 2014 FTC, GeneLink and Subsidiary Reach Deal to Settle Charges of False Advertising Jun 6, 2013 Thermo Fisher Plans Public Offering of $2.2B to Fund Life Tech Buy; Expects Another FTC Request Jan 8, 2013 Illumina Withdraws Complete Genomics Bid Jan 7, 2013 BGI Bid to Acquire Complete Genomics Passes US Antitrust Hurdle; Tender Offer Extended Again Nov 6, 2012 FTC Wants More Information About BGI-Shenzhen Buy of Complete Genomics Dec 8, 2011 LabCorp's Bid for Orchid Cellmark Finally Cleared by FTC Nov 7, 2011 LabCorp Extends Proposed Orchid Cellmark Buy Again Oct 20, 2011 PerkinElmer Acquisition of Caliper Clears Anti-Trust Review Sep 12, 2011 LabCorp Extends Offer for Orchid for Sixth Time Jun 16, 2011 LabCorp Further Extends Offer for Orchid Cellmark May 18, 2011 LabCorp Extends Tender Offer for Orchid Cellmark as FTC Requests More Information Mar 9, 2011 FTC Clears Danaher's Proposed Acquisition of Beckman Coulter Nov 18, 2010 LabCorp Buy of Genzyme Genetics Clears FTC Feb 10, 2010 Myriad Defends Policy of Urging Docs to Genetically Counsel BRACAnalysis Customers Premium Jan 22, 2010 European Commission OKs Agilent's Acquisition of Varian; FTC Approval Still Pending Premium Nov 3, 2009 FTC Asks MDS, Danaher for More Information on Acquisition Sep 30, 2009 What's In a Name? Experts Question Bill Calling DTC Genomics 'Post-CLIA Bioinformatics Services' Premium Apr 22, 2009 Snippets: Apr 22, 2009 Premium Apr 15, 2009 Tech Transfer Tidbits: Apr 15, 2009 Premium Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.